Gene:
SCG5
secretogranin V (7B2 protein)

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

Overview

Alternate Names:  SGNE1; prohormone convertase chaperone
Alternate Symbols:  7B2; SgV
PharmGKB Accession Id: PA35724

Details

Cytogenetic Location: chr15 : q13.3 - q14
GP mRNA Boundary: chr15 : 32933757 - 32989299
GP Gene Boundary: chr15 : 32923757 - 32992299
Strand: plus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.
No related genes are available

Curated Information ?

Evidence Disease
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Colorectal Neoplasms

Publications related to SCG5: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nature genetics. 2008. Jaeger Emma, et al. PubMed

LinkOuts

NCBI Gene:
6447
OMIM:
173120
UCSC Genome Browser:
NM_003020
RefSeq RNA:
NM_001144757
NM_003020
RefSeq Protein:
NP_001138229
NP_003011
RefSeq DNA:
NT_010194
UniProtKB:
7B2_HUMAN (P05408)
Q6FHD0_HUMAN (Q6FHD0)
Ensembl:
ENSG00000166922
GenAtlas:
SCG5
GeneCard:
SCG5
MutDB:
SCG5
ALFRED:
LO037123Q
HuGE:
SCG5
Comparative Toxicogenomics Database:
6447
HumanCyc Gene:
HS09480
HGNC:
10816

Common Searches